強気
$128.92
シナリオ価格
$118.210
+1.797 (+1.52%)終値時点
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance.
Aflac Inc is currently a hold. The stock is priced at $114.54, with a forward P/E ratio of 15.20, indicating it is fairly valued compared to its earnings growth potential. However, the RSI is at 59.41, suggesting it is nearing overbought territory. The main risk is the downgrade from Mizuho, which lowered its price target to $107, indicating potential downside from current levels.
BofA
$133
2026-10-12
BofA
2026-10-12
目標株価
$133
Mizuho
$107
2026-10-07
Mizuho
2026-10-07
目標株価
$107
Barclays
$101
2026-10-07
Barclays
2026-10-07
目標株価
$101
UBS
$125
2026-10-06
UBS
2026-10-06
目標株価
$125
Wells Fargo
$122
2026-08-19
Wells Fargo
2026-08-19
目標株価
$122
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Aflac Study Reveals Legacy Planning Gaps for U.S. Workforce

Aflac Study Reveals Legacy Planning Gaps for U.S. Workforce

Brian Jordan Brings Hope to Children with Cancer

Brian Jordan Brings Hope to Children with Cancer

Aflac and Rachel Zoe Launch Cancer Screening Jacket
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).
Aflac Inc is currently a hold. The stock is priced at $114.54, with a forward P/E ratio of 15.20, indicating it is fairly valued compared to its earnings growth potential. However, the RSI is at 59.41, suggesting it is nearing overbought territory. The main risk is the downgrade from Mizuho, which lowered its price target to $107, indicating potential downside from current levels.
15 analysts cover AFL: 3 rate it Buy, 10 Hold and 2 Sell. The average price target is 110.90.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。